IRME (IR-Med) Research & Development: $0.67 Mil (TTM As of Jun. 2025)


What is IR-Med Research & Development?

IR-Med IRME Research & Development is $0.67 Mil as of Jun. 2025. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. IR-Med's Research & Development for the three months ended in Jun. 2025 was $0.09 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was $0.67 Mil.

IR-Med  (OTCPK:IRME) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

IR-Med Research & Development Related Terms

IR-Med Research & Development Historical Data

* Premium members only.

The historical data trend for IR-Med's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IR-Med Research & Development Chart

IR-Med Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
0.41 1.42 1.89 2.06 1.18

IR-Med Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.26 0.30 0.02 0.09

IR-Med Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.67 Mil mean?
IR-Med (IRME) has a Research & Development of $0.67 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on IR-Med and its competitors.
Is IR-Med's Research & Development too high?
IR-Med's current Research & Development is $0.67 Mil.
How does IR-Med's Research & Development compare to SSKN and NUMD?
IR-Med's Research & Development of $0.67 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on IR-Med and its competitors. IR-Med's current Research & Development is $0.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IR-Med stock overvalued right now?
IR-Med (IRME) has a current Research & Development of $0.67 Mil. The current Research & Development is $0.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For IR-Med (IRME), the current Research & Development is $0.67 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IR-Med Business Description

Address Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400
IR-Med Inc is a development-stage medical device company that is developing its technology through its Subsidiary and utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology to develop non-invasive devices for various medical indications. These devices detect and measure biomarkers and molecules in blood and human tissue in real-time.